BETHESDA, Md., Nov. 12, 2019 /PRNewswire/ -- Nearly one million US adults get pneumococcal pneumonia each year, yet a recent survey

CARLSBAD, Calif., Nov. 12, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced that management will present a company overview at the following investor conferences:

CSE: JANEOTCQB: HHPHFFSE: 0HCNExpands universe of addressable U.S. investors TORONTO, Nov. 12, 2019 /PRNewswire/ - Mojave Jane (CSE: HC) (OTCQB: HHPHF) (FSE: OHCN), a California cannabis company, today announced that the Company's shares in the U.S. have mig

SAN FRANCISCO, Nov. 12, 2019 /PRNewswire/ -- Carrum Health, the first cloud-based platform connecting employers and employees with Centers of Excellence (COE) for surgical procedure

ROCKVILLE, Md. and BEIJING, Nov. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, today reported financial results for the third quarter and nine months ended September 30, 2019.

PRINCETON, N.J., Nov. 12, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended

SAN FRANCISCO, Nov. 12, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today reported third quarter 2019 financial results for the period ending Septembe

HOLLISTON, Mass., Nov. 12, 2019 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced its financial results for th

DUBLIN, Nov. 12, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the receipt of a $150 million milestone payment from Biogen triggered by the recen

JERUSALEM, Nov. 12, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three and nine months ended September 30, 2019.Highlights of the third quarter 2019 and recent weeks include: Presented two posters highlighting data from the Com